DDX3X loss is an adverse prognostic marker in diffuse large B-cell lymphoma and is associated with chemoresistance in aggressive non-Hodgkin lymphoma subtypes

Bibliographic Details
Main Authors:	Kizhakeyil, A, Zaini, NBM, Poh, ZS, Wong, BHS, Loh, X, Ng, AS, Low, ZS, Prasannan, P, Gong, C, Tan, MGK, Nagarajan, C, Huang, D, Lu, PW, Lim, JQ, Barrans, S, Ong, CK, Lim, ST, Chng, WJ, Follows, G, Hodson, DJ, Du, MQ, Goh, YT, Tan, SH, Grigoropoulos, NF, Verma, NK
Format:	Journal article
Language:	English
Published:	BioMed Central 2021

Similar Items